tiprankstipranks
Structure Therapeutics, Formerly ShouTi, Files for U.S. IPO
Market News

Structure Therapeutics, Formerly ShouTi, Files for U.S. IPO

Story Highlights

Structure Therapeutics, which develops drugs for pulmonary, metabolic, and cardiovascular diseases, intends to raise $100 million via IPO.

Clinical-stage biopharmaceutical company Structure Therapeutics has filed for an initial public offering (IPO) in the U.S. in a bid to raise $100 million. The company was formerly known as ShoutTi.

Pick the best stocks and maximize your portfolio:

The global drug maker is incorporated in the Cayman Islands and has operations in the U.S. and China. The company is looking to list its American Depositary Shares (ADS) on Nasdaq under the symbol GPCR.

The company develops drugs that target G-protein receptors, or GPCRs. These drugs are used in treating pulmonary, metabolic, and cardiovascular diseases.

Jefferies, SVB Securities, Guggenheim Securities, and BMO Capital Markets are initiating the IPO.

Structure Therapeutics, which brings computational techniques to drug-making, raised $100 million in Series B financing in October 2021. The company designs small molecules to replace biologic and peptide drugs.

Disclosure

Related Articles
Radhika SaraogiStock Market News Today, 12/12/24 – Indices Fall on Disappointing Data
Joel BagloleServiceTitan (TTAN) Stock Soars 42% in Market Debut
Radhika SaraogiSuper Micro Computer Stock (SMCI) Falls Hard Despite CEO’s Assurance
Go Ad-Free with Our App